Meghana V Trivedi

15PUBLICATIONS
11CO-AUTHORS
Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseasePredictive and prognostic markersNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 14, 2025
Group-Based Trajectory Model to Assess Adjuvant Endocrine Therapy Adherence Pattern in HR-Positive Breast Cancer: Results from Rio Grande Valley Patients.

Bilqees Fatima, Phillip Shayne Pruneda, Parasto Mousavi

|Apr 16, 2025
Non-adherence of cyclin-dependent kinases 4 and 6 inhibitors reduces overall and progression-free survival in patients with hormone receptor-positive breast cancer.

Connie Lau, Krista LaBorde, Bilqees Fatima

|Mar 07, 2025
Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area.

Yashvi Patel, Hasan Alsaedi, Zahra Majd

|Feb 18, 2025
Interactions between ADGRF1 (GPR110) and extracellular matrix proteins govern its effects on tumorigenesis in HER2-positive breast cancer.

Noor Mazin Abdulkareem, Raksha Bhat, Micah Castillo

|Jun 28, 2023
Adherence to oral endocrine therapy in racial/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic.

Sama Rahimi, Onyebuchi Ononogbu, Anjana Mohan

|Mar 15, 2023
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA.

Prajakta P Masurkar, Haluk Damgacioglu, Ashish A Deshmukh

Pageof 3

Frequent Collaborators

2 joint publications

Ekim Ekinci

2 joint publications

Tao Wang

1 joint publications

Luigi Coppola

1 joint publications

Roberto Bianco